Novo CEO Calls Workforce Back to Office for Obesity Drug Battle

Novo Nordisk A/S’s new chief executive officer is calling workers back to the office as the Ozempic maker struggles to catch up with Eli Lilly & Co. in the hyper-competitive obesity market.

Office-based employees will need to come in five days a week starting Jan. 1, Novo said Thursday. The move comes a day after CEO Maziar Mike Doustdar announced the Danish drugmaker would slash its workforce by 11%.

Read More: Novo Tries to Catch Up With Lilly by Slashing 11% of Workforce

Novo didn’t previously have a global policy on working from home, a common perk for Danish ...